Form 4 Tracker
Kura Oncology, Inc.
KURA

31 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 21, 2026Aug 24 9:30 PMBrian T. PowlChief Commercial Officer
Sale
4,345$11.89$51.7K169,269(D)

View →

Aug 21, 2026Aug 21 8:41 PMBRIAN POWL
Proposed Sale
4,345$11.71$50.9K—

View →

Aug 19, 2026Aug 21 8:30 PMTeresa Brophy BairChief Legal Officer
Sale
31,487$12.63$397.7K195,444(D)

View →

Aug 19, 2026Aug 19 8:24 PMTERESA BAIR
Proposed Sale
31,487$12.33$388.2K—

View →

Aug 17, 2026Aug 17 8:45 PMTroy Edward WilsonDirector, President and CEO
Purchase
100,000$11.12$1.1M379,194(I)

View →

Jun 18, 2026Jun 22 10:00 PMMollie LeoniChief Medical Officer
Sale
84,929$9.82$834.3K182,345(D)

View →

Jun 18, 2026Jun 18 8:23 PMMOLLIE VANESSA LEONI
Proposed Sale
84,929$9.57$812.8K—

View →

May 21, 2026May 22 8:05 PMBrian T. PowlChief Commercial Officer
Sale
10,000$11.00$110.0K173,614(D)

View →

May 21, 2026May 21 8:31 PMBRIAN POWL
Proposed Sale
10,000$10.34$103.4K—

View →

May 19, 2026May 20 8:05 PMBrian T. PowlChief Commercial Officer
Sale
339$9.21$3.1K183,614(D)

View →

May 19, 2026May 20 8:05 PMKathleen FordChief Operating Officer
Sale
2,257$9.08$20.5K153,560(D)

View →

May 18, 2026May 20 8:05 PMTeresa Brophy BairChief Legal Officer
Sale
2,256$9.38$21.2K226,931(D)

View →

May 19, 2026May 19 8:39 PMKATHLEEN FORD
Proposed Sale
2,257$9.20$20.8K—

View →

May 19, 2026May 19 8:37 PMBRIAN POWL
Proposed Sale
339$9.20$3.1K—

View →

May 18, 2026May 18 8:31 PMTERESA BAIR
Proposed Sale
2,256$9.22$20.8K—

View →

Jan 27, 2026Jan 28 2:35 AMBrian T. PowlChief Commercial Officer
Sale
6,414$8.46$54.3K183,275(D)

View →

Jan 27, 2026Jan 28 2:35 AMKathleen FordChief Operating Officer
Sale
1,813$8.46$15.3K153,560(D)

View →

Jan 27, 2026Jan 28 2:35 AMMollie LeoniChief Medical Officer
Sale
8,180$8.46$69.2K267,274(D)

View →

Jan 27, 2026Jan 28 2:35 AMThomas James DoyleSVP, Finance & Accounting
Sale
7,142$8.46$60.4K145,167(D)

View →

Jan 27, 2026Jan 28 2:35 AMFrancis BurrowsChief Scientific Officer
Sale
1,311$8.46$11.1K32,424(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 24, 2026Sep 25 8:05 PMFrancis BurrowsChief Scientific Officer
Option Exercise
30,000$6.150(D)

View →

Sep 8, 2026Sep 10 8:30 PMJennifer FulkChief Financial Officer
Grant/Award
450,000$12.52450,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMDiane L. ParksDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMMichael VasconcellesDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMHasnain FaheemDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMHelen Louise CollinsDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMCarol SchaferDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMMary T SzelaDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMThomas MalleyDirector
Grant/Award
35,000$8.7735,000(D)

View →

Mar 23, 2026Mar 25 1:00 PMTroy Edward WilsonDirector, President and CEO
Option Exercise
6,103$6.150(D)

View →

Mar 18, 2026Mar 20 1:00 PMThomas MalleyDirector
Option Exercise
10,000$3.120(D)

View →